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Objectives: To study the use of carbon dioxide as a contrast medium for arteriography. 
Methods: Carbon dioxide was used as a contrast medium for intra-arterial digital subtraction lower limb angiography in 
12 examinations on 11 patients. 
Results: No complication was encountered and no significant changes occurred in the arterial pH, PaC02 and Pa02. The 
quality of images as assessed by an independent observer was adequate for the majority of the vessels (77%). 
Conclusions: Carbon dioxide is a safe alternative in patients at an increased risk of adverse reaction to iodinated ionic or 
non-ionic ontrast medium and is very cheap. 
Introduction 
Modern non-ionic low osmolar contrast media are 
relatively safe and produce good quality angiographic 
images. However, their use is not entirely free from 
problems in certain situations. Nephrotoxicity is a well 
recognized side effect of intravascular contrast. The 
risk of renal damage is particularly high in patients 
with diabetes, hypertension, dehydration, multiple 
myeloma and in the presence of impaired renal 
function; 1 conditions which often co-exist with periph- 
eral vascular disease. The risk of allergic reaction to 
iodine containing contrast has been estimated to be 
4-7% in atopic individuals, 2 rising to 38% in those 
with a previous history of adverse reaction to con- 
trast. 3Rapid injection of contrast can result in pulmo- 
nary oedema particularly in patients with poor ven- 
tricular function. 4 Carbon dioxide has been used 
successfully in the past as a negative contrast for 
cystogram, s arthrogram 6 and angiogram. 7"s In the 
present study CO2 has been evaluated in a prospective 
controlled study as an angiographic contrast medium 
during digital subtraction peripheral angiography. 
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Twelve examinations were performed on 11 patients 
with a median age of 72 years (range 67-82 years). All 
the patients were being investigated for peripheral 
vascular disease. Approval was obtained from the 
University Hospital Ethics Committee and informed 
consent was obtained from the patients. Angiography 
was performed with both Iopamidol (Niopam, E. 
Merck Ltd) and Carbon dioxide in 9/12 procedures 
and CO2 was used alone in three examinations. Of 
these three procedures two were performed in a 
patient with a history of severe adverse reaction to 
iodinated contrast and another patient had refractory 
cardiac failure. Anterior femoral wall puncture tech- 
nique was used for the introduction of a 5 F 
angiographic flush catheter. Iopamidol injections were 
carried out with the catheter in the abdominal aorta. 
For CO2 injections the catheter was withdrawn into 
the external i iac and direct intra-aortic injection was 
avoided. Medical grade CO2 (BOC Medical gases, 
Guildford, Surrey U.K.) was drawn into a 60 ml 
syringe from a laparoscopic insuffiator. The syringe 
was flushed with CO2 a few times to eliminate any air 
and ipsilateral images were obtained following rapid 
hand injection of 50 ml of CO2 for each run. The leg 
was elevated approximately 20 ° to facilitate the 
forward flow of CO2 aided by buoyancy. Arterial 
blood gases were obtained before and within i min of 
completion of the study in 10/12 cases and analysed 
for pH, PaCO~. and PaO2 on a blood gas analyser. 
Patients and Methods 
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Paired images obtained with Niopam and CO2 were 
blindly assessed by MJH (a vascular adiologist from 
another egion) without any knowledge of the nature 
of the study. He was asked to select he better image in 
each pair and using it as the standard, grade individ- 
ual vessels in the other image as adequate or inade- 
quate on the criteria that no important clinical infor- 
mation was missing or misinformation was present. 
Statistical analysis was performed by using Wilcoxon 
paired rank signed test for comparing the changes in 
arterial blood before and after the procedure. 
Results 
(1) No complication occurred in any of the 
procedure. 
(2) The median volume of CO2 used was 200 ml (range 
200-300 ml). 
(3) There was no significant change in the arterial pH, 
PaCO2 and PaO2 following CO2 angiography (Figs. 
1, 2 and 3). 
(4) In each pair the image obtained with Niopam was 
selected as the better image. 
(5) The quality of images were totally adequate in the 
Femoral and popliteal regions. Overall 23% of the 
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Fig. 1. Changes in the arterial pH following C02 angiography. 
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Fig. 3. Changes in Pa02 following C02 angiography. 
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images were deemed to be inadequate. Of these 6% 
were iliac and 17% were tibial images. 
(6) Bilateral superficial femoral angioplasties were 
performed on two separate occasions on one 
patient who had a history of major adverse 
reaction to iodinated contrast with good radi- 
ological, haemodynamic and clinical result (Fig. 
4). 
(7) One diagnostic examination was successfully car- 
ried out with a 20 G cannula placed in the femoral 
artery. 
Discussion 
Carbon dioxide (CO2) has been used as a radiological 
contrast medium for more than three decades. 5 As an 
angiographic contrast medium CO2 has been in use 
since 1968 by Bendib et al. 7 who has reported 
uncomplicated use of intravenous CO2 in more than 
1600 patients for diagnostic study of the right side of 
the heart. In patients with peripheral vascular disease 
CO2 was first used intra-arterially as a vasodilator 
agent by Bartley et al. 9 more than 20 years ago. During 
subsequent study on therapeutic use of CO2 in 
patients with peripheral occlusive arterial disease by 
the same group, 1° it was observed that CO2 delineated 
the artery by acting as a negative radiological contrast. 
Since then Hawkins and Herrera s have reported safe 
use of COz for angiography in more than 300 patients. 
However, in Europe the use of CO2 as a contrast 
medium for peripheral angiography has not been 
widely reported. Moreover, the quality of images 
obtained uring peripheral digital subtraction arter- 
iography using CO2 and non-ionic iodinated contrast 
has not been compared in the past. 
The important risk factors related to contrast 
Fig. 4. (left) Superficial femoral rtery stenosis demonstrated with CO 2 angiography. (right) Post angioplasty. 
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medium induced renal damage are pre-existing renal 
insufficiency, diabetes mellitus with the risk becoming 
more significant in patients with diabetic nephrop- 
athy. In a prospective study of non diabetic patients 
with impaired renal function undergoing intravenous 
urography (IVU) the incidence of acute renal failure 
has been reported to be as high as 62%. 12 Patients 
undergoing IVU are more likely to have impaired 
renal function than those undergoing arteriography 
but the volume of contrast used for peripheral 
angiography is nearly three to four times greater than 
the volume used for IVU and there is some suggestion 
that the nephrotoxicity may be dose related. CO2 
could therefore be used as an alternative for a teriog- 
raphy in patients with impaired renal function, dia- 
betic nephropathy and multiple myeloma who are at 
an increased risk of contrast induced renal damage. 
The iodine load following injection of 100 ml of tri- 
iodinated non ionic contrast medium could be 3-4 g. 
This could produce hyperthyroidism in euthyroid 
Ca) (b) 
Fig. 5. (a) Ipsilateral digital subtraction angiography with intra-arterial CO2 injection. (b) Paired image obtained withNiopam 300 
(Merck Ltd.). 
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individuals with autonomous thyroid nodules ~3 and 
CO2 again offers a safe alternative in such patients. 
In patients with impaired ventricular function, 
injection of osmolar contrast medium can lead to 
pulmonary oedema particularly when the volume 
injected exceeds 200 ml. 4 CO 2 does not add to the 
circulatory fluid load and could again be useful in 
such patients. 
One other advantage of COz is its low viscosity 
Fig. 6. Popliteal and tibial arteries demonstrated with CO2 intra- 
arterial digital subtraction a giography. 
which is almost 400 times less than the conventional 
mono acid monomeric salt contrast medium. 1° This 
means that angiography can be performed via rela- 
tively fine catheters and small puncture in the femoral 
artery. In the present study we were able to perform 
the procedure with a 20 G cannula (Viggo, Spec- 
tramed) instead of the standard 4 or 5 F catheter. 
Because there is some evidence from animal studies 
that CO2 may be neurotoxic, 14 we avoided direct 
aortic injection to avoid any adverse effect on the 
spinal cord. The visualisation of the proximal iliac was 
therefore dependent upon reflux of the CO2 and could 
account for the 6% of the inadequate images being in 
the iliac region (Fig. 5a). It seems likely that antegrade 
filling of the iliac artery from aortic injection would 
overcome this problem. Of the inadequate images 17% 
were in the tibial region. In some studies fragmenta- 
tion of the column of CO 2 was seen in the tibial vessel 
(Fig. 5a). It appears to be related to slow transit in 
patients with poor ventricular function. However, the 
visualisation of tibial vessels was not a consistent 
problem and good images were also obtained (Fig. 
6). 
Cost is an important consideration. A cylinder of 
COz containing 450 1 of medical grade CO2 costs less 
than 100 ml of non-ionic contrast. In other words, the 
contrast cost of angiography with non-ionic contrast is 
1000 fold greater than CO2. However, the overall cost 
benefit may not be a significant one if CO2 is used only 
selectively in a relatively small number of patients at 
an increased risk of adverse reaction to iodinated 
intravascular contrast. 
In the present study no complication was encoun- 
tered and no significant changes were observed in the 
arterial pH and gases. This is somewhat expected 
since the volume of COz used for each study was close 
to the amount excreted by the body each minute at 
rest. C02 injection ot only enabled iagnostic angiog- 
raphy but angioplasty was also performed in a patient 
with bilateral SFA stenosis who had a major adverse 
reaction to iodinated contrast in the past. Duplex scan 
guided angioplasty which requires two operators is 
another technique that can enable angil"oplasty without 
the use of intravascular contrast. With further 
experience it may provide another safe alternative for 
localised studies and angioplasty. 
In summary, COa is safe and effective as a contrast 
medium during peripheral angiography with digital 
subtraction imaging. It could be used as an alternative 
in patients with history of adverse reaction to iodi- 
nated contrast and those individuals who are at an 
increased risk of renal damage and pulmonary 
oedema from the conventional intravascular 
contrast. 
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